Search company, investor...

Orphanix

orphanix.com

Founded Year

2015

About Orphanix

Orphanix develops drug therapies for neglected and rare diseases called orphan diseases. It identifies, develops, and commercializes medicinal products to solve high unmet medical needs in the paediatric rare disease space. Orphanix was founded in 2015 and is based in Linz, Austria.

Headquarters Location

Lederergasse 18/1

Linz, 4020,

Austria

Missing: Orphanix's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Orphanix's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Orphanix Patents

Orphanix has filed 1 patent.

The 3 most popular patent topics include:

  • Diseases of liver
  • Diseases of the eye and adnexa
  • Hepatology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/26/2019

Hepatology, Diseases of the eye and adnexa, Diseases of liver, Rare diseases, Pediatrics

Application

Application Date

11/26/2019

Grant Date

Title

Related Topics

Hepatology, Diseases of the eye and adnexa, Diseases of liver, Rare diseases, Pediatrics

Status

Application

Latest Orphanix News

BRIEF—Aspire in-licenses Retinolx from Orphanix

Aug 16, 2022

16-08-2022 Anglo-American firm Aspire Pharma has in-licensed Retinolx (vitamin A) from Orphanix, an Austrian biopharma focussed on the development of novel therapeutic orphan drugs across a range of pediatric therapy areas. Retinolx brings Aspire a therapeutic candidate in bronchopulmonary dysplasia (BPD) and retinopathy of prematurity (ROP) in pre-term infants. It allows the option for both intramuscular and intravesical administration. Richard Condon, chief executive of Aspire, said: “This acquisition demonstrates our commitment to advance the science and treatment options for orphan drug designations in vulnerable patient groups. Through our in-house expertise and network of global leaders in these respective fields, we strive to bring breakthrough advances in clinical management.” Financial terms of the deal have not been disclosed.

Orphanix Frequently Asked Questions (FAQ)

  • When was Orphanix founded?

    Orphanix was founded in 2015.

  • Where is Orphanix's headquarters?

    Orphanix's headquarters is located at Lederergasse 18/1, Linz.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.